- Home
- SMTI vs KOD Comparison
SMTI vs KOD Comparison
Compare SMTI & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- KOD
- Stock Information
- Founded
- SMTI 1982
- KOD 2009
- Country
- SMTI United States
- KOD United States
- Employees
- SMTI N/A
- KOD N/A
- Industry
- SMTI Medical/Dental Instruments
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMTI Health Care
- KOD Health Care
- Exchange
- SMTI Nasdaq
- KOD Nasdaq
- Market Cap
- SMTI 243.3M
- KOD 198.4M
- IPO Year
- SMTI N/A
- KOD 2018
- Fundamental
- Price
- SMTI $25.53
- KOD $8.84
- Analyst Decision
- SMTI Strong Buy
- KOD Hold
- Analyst Count
- SMTI 2
- KOD 3
- Target Price
- SMTI $49.50
- KOD $9.00
- AVG Volume (30 Days)
- SMTI 60.3K
- KOD 549.8K
- Earning Date
- SMTI 08-13-2025
- KOD 08-13-2025
- Dividend Yield
- SMTI N/A
- KOD N/A
- EPS Growth
- SMTI N/A
- KOD N/A
- EPS
- SMTI N/A
- KOD N/A
- Revenue
- SMTI $91,569,883.00
- KOD N/A
- Revenue This Year
- SMTI $22.70
- KOD N/A
- Revenue Next Year
- SMTI $13.56
- KOD N/A
- P/E Ratio
- SMTI N/A
- KOD N/A
- Revenue Growth
- SMTI 34.65
- KOD N/A
- 52 Week Low
- SMTI $25.02
- KOD $1.92
- 52 Week High
- SMTI $39.08
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- SMTI 35.12
- KOD 84.50
- Support Level
- SMTI $25.02
- KOD $5.00
- Resistance Level
- SMTI $27.67
- KOD $5.73
- Average True Range (ATR)
- SMTI 1.32
- KOD 0.70
- MACD
- SMTI -0.28
- KOD 0.42
- Stochastic Oscillator
- SMTI 8.61
- KOD 99.61
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.